FDA Inspection 1110711 — Mayne Pharma International PTY LTD
The FDA completed an inspection of Mayne Pharma International PTY LTD on October 18, 2019 in Salisbury South. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 18, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Salisbury South (Australia)